Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Undervalued Apricus Bio Poised to Follow Threshold Pharma in Receiving SPA Approval
Undervalued Apricus Bio Poised to Follow Threshold Pharma in Receiving SPA Approval
Undervalued Apricus Bio Poised to Follow Threshold Pharma in Receiving SPA Approval
Submitted by
admin
on February 17, 2011 - 1:02pm
Source:
Seeking Alpha
News Tags:
Apricus Biosciences
liver cancer
ProvOnco
Threshold Pharmaceuticals
Headline:
Undervalued Apricus Bio Poised to Follow Threshold Pharma in Receiving SPA Approval
Do Not Allow Advertisers to Use My Personal information
